Compare CRMD & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRMD | PHK |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 561.8M | 844.1M |
| IPO Year | 2009 | N/A |
| Metric | CRMD | PHK |
|---|---|---|
| Price | $6.25 | $4.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.67 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 653.9K |
| Earning Date | 06-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.61% |
| EPS Growth | ★ 780.00 | N/A |
| EPS | ★ 2.04 | N/A |
| Revenue | ★ $311,709,000.00 | N/A |
| Revenue This Year | $1.10 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.14 | ★ N/A |
| Revenue Growth | ★ 617.03 | N/A |
| 52 Week Low | $5.60 | $4.18 |
| 52 Week High | $17.43 | $5.04 |
| Indicator | CRMD | PHK |
|---|---|---|
| Relative Strength Index (RSI) | 34.65 | 18.69 |
| Support Level | $6.13 | N/A |
| Resistance Level | $7.44 | $4.91 |
| Average True Range (ATR) | 0.30 | 0.05 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 11.03 | 1.56 |
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. The secondary objective of the company is to seek capital appreciation.